JOHANNESBURG (Reuters) - South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising. The health department selected four pharmaceutical companies, including Africa's biggest generic drugmaker Aspen Pharmacare, to make and supply the drugs to public hospitals. Aspen was awarded 2.5 billion rand ($214 million), India's Cipla Ltd 2 billion rand, U.S-based Mylan 2.8 billion rand and unlisted South African firm Sonke 3 billion rand. ...
via Health News Headlines - Yahoo News http://ift.tt/1wENRCh
No comments:
Post a Comment